NCT06404632

Brief Summary

Health-related habits influences mental and physical health. Still, treatment of health-related habits, which can help to remedy health problems, is often not done at all or very superficially. Multiple guidelines emphasize the importance of prioritizing health-related habits, but there is a lack of implemented models. To solve this, the investigators have developed a transdiagnostic, interprofessional material intended for several care settings. The Lev-g intervention is intended for groups. There is also an individual version of Lev that has its on registration in Clinical Trails.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2024

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 8, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 13, 2024

Status Verified

May 1, 2024

Enrollment Period

1.7 years

First QC Date

May 5, 2024

Last Update Submit

May 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Completion rate participants

    How many of the participants that started using Lev (i.e., completing screening with Lev-s) completed Lev (i.e., completing, 3 out of 4 session)

    within 3-4 months

Secondary Outcomes (22)

  • Level of treatment credibility participants

    Before and after taking part in Lev (after refers to completing the three sessions i.e, not including the booster session after three months). I.e within 6 weeks

  • Level of treatment credibility healthcare workers

    Before and after taking part in Lev (after refers to completing the three sessions i.e, not including the booster session after three months)I.e within 6 weeks

  • Treatment satisfaction participants (individual sessions)

    After completing the first session in Lev. An average of 1-2 weeks from baseline

  • Treatment satisfaction participants (individual sessions)

    After completing the second session in Lev. An average of 2-3 weeks from baseline

  • Treatment satisfaction participants (individual sessions)

    After completing the third session in Lev. An average of 3-4 weeks from baseline

  • +17 more secondary outcomes

Study Arms (1)

Lev-g (group intervention)

EXPERIMENTAL

Lev-g includes three sessions + a booster session using psychoeducation, motivational interviewing, and applied behavioral analyses. Lev-g is done in groups to enable support and tips from others. There is no control condition. Only one arm to test feasibility.

Behavioral: Lev-g

Interventions

Lev-gBEHAVIORAL

Lev-g includes three sessions + a booster session using psychoeducation, motivational interviewing, and applied behavioral analyses. Lev-g is done in groups to enable support and tips from others.

Lev-g (group intervention)

Eligibility Criteria

Age15 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • both adults with and without disabilities recruited from different healthcare contexts.

You may not qualify if:

  • Intellectual disability of the degree where the participant is not able to follow the protocol in Lev.
  • Insufficient command of the Swedish language/ unable to understand the content.
  • Severe psychiatric comorbidity that makes participation difficult (e.g. severe depression, severe suicidality, severe anxiety, ongoing psychosis, manic episode), other circumstances that could make participation hard (e.g. homelessness).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Region Stockholm

Stockholm, Stockholm, Sweden, 104 31, Sweden

RECRUITING

MeSH Terms

Conditions

Health BehaviorPatient Acceptance of Health Care

Condition Hierarchy (Ancestors)

BehaviorTreatment Adherence and Compliance

Study Officials

  • Douglas Sjöwall, PhD

    Region Stockholm

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Douglas Sjöwall, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Feasibility trial with pre, peri, post and follow-up measurements
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Associate professor

Study Record Dates

First Submitted

May 5, 2024

First Posted

May 8, 2024

Study Start

April 12, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

May 13, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Douglas Sjöwall will be responsible for granting access to data only to researchers who are participating in the publications

Locations